Arrayit

The deal brings together three firms that have struggled to ramp their test businesses in hopes that the combined outfit will be better positioned to succeed.

Arrayit also alleged that the actions of an investor suing the company threatens a company contract with the US Department of Agriculture.

In a letter to a New York court, the investor alleged that Arrayit has failed to meet the terms of a settlement that was supposed to end litigation filed last year.

The partners will collaborate to develop and validate a high-throughput DNA microarray-based detection system to monitor foodborne bacteria and viruses. 

NEW YORK (GenomeWeb) – Avant Diagnostics plans to go public through a reverse merger effective Oct.

NEW YORK (GenomeWeb) – American Liberty Petroleum Corp. has announced plans to acquire Avant Diagnostics, a Scottsdale, Ariz.-based company seeking to commercialize OvaDx, a microarray-based test for early stage ovarian cancer detection.

NEW YORK (GenomeWeb) – Arrayit disclosed in a regulatory filing this week that a lawsuit filed by an investor against several members of its management team has recently been dismissed.

NEW YORK (GenomeWeb) – Arrayit today said that it has signed a distribution agreement with VigeneTech, bundling that firm's protein microarray suite of software with Arrayit's protein microarray platform.

NEW YORK (GenomeWeb) – Arrayit today reported a 15 percent spike in first quarter sales driven by sales of microarray instruments.
Total revenues for the three months ended March 31 were $1.1 million up from $942,916 in the first quarter of 2013.

NEW YORK (GenomeWeb News) – Arrayit said today it has inked a professional services master agreement with Diagnostic Oncology Research Organization to aid it in obtaining approval from the US Food and Drug Administration for its tests.

Pages

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.